From Name:
From Email:
To Name:
To Email:

Optional Message:


Biotech startup puts new spin on regenerative medicine for nervous system repair

from MedCity News

An early-stage Midwest biotech startup with a unique approach to treating damaged nervous system tissue is looking for its first round of capital. Axonia Medical has raised $1 million of the $3 million it hopes to secure in a Series A financing that would carry the Kalamazoo, Michigan-based biotech through large-animal trials of its regenerative nervous system repair technology. The nervous system has a limited ability to repair itself after injury, and there is a lack of effective treatment options to restore function, especially in brain and spinal cord injuries, according to Axonia Co-founder, President and CEO Harry Ledebur. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063